Cargando…
Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049313/ https://www.ncbi.nlm.nih.gov/pubmed/30035160 http://dx.doi.org/10.18632/oncoscience.416 |
| _version_ | 1783340221497081856 |
|---|---|
| author | Seguin, Laetitia Féral, Chloé |
| author_facet | Seguin, Laetitia Féral, Chloé |
| author_sort | Seguin, Laetitia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6049313 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60493132018-07-22 Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer Seguin, Laetitia Féral, Chloé Oncoscience Editorial Impact Journals LLC 2018-06-23 /pmc/articles/PMC6049313/ /pubmed/30035160 http://dx.doi.org/10.18632/oncoscience.416 Text en Copyright: © 2018 Seguin and Féral http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Editorial Seguin, Laetitia Féral, Chloé Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer |
| title | Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer |
| title_full | Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer |
| title_fullStr | Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer |
| title_full_unstemmed | Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer |
| title_short | Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer |
| title_sort | personalized medicine: exploiting druggable vulnerabilities for kras-driven lung cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049313/ https://www.ncbi.nlm.nih.gov/pubmed/30035160 http://dx.doi.org/10.18632/oncoscience.416 |
| work_keys_str_mv | AT seguinlaetitia personalizedmedicineexploitingdruggablevulnerabilitiesforkrasdrivenlungcancer AT feralchloe personalizedmedicineexploitingdruggablevulnerabilitiesforkrasdrivenlungcancer |